WAC 296-155-17327
Medical surveillance. (1) General.
(a) The employer shall make available a medical
surveillance program for employees exposed to MDA under the
following circumstances:
(i) Employees exposed at or above the action level for
thirty or more days per year;
(ii) Employees who are subject to dermal exposure to MDA
for 15 or more days per year;
(iii) Employees who have been exposed in an emergency
situation;
(iv) Employees whom the employer, based on results from
compliance with WAC 296-155-17311(8) has reason to believe are
being dermally exposed; and
(v) Employees who show signs or symptoms of MDA exposure.
(b) The employer shall ensure that all medical
examinations and procedures are performed by or under the
supervision of a licensed physician at a reasonable time and
place, and provided without cost to the employee.
(2) Initial examinations.
(a) Within one hundred fifty days of the effective date
of this standard, or before the time of initial assignment,
the employer shall provide each employee covered by subsection
(1)(a) of this section with a medical examination including
the following elements:
A detailed history which includes:
(i) Past work exposure to MDA or any other toxic
substances;
(ii) A history of drugs, alcohol, tobacco, and medication
routinely taken (duration and quantity); and
(iii) A history of dermatitis, chemical skin
sensitization, or previous hepatic disease.
(iv) A physical examination which includes all routine
physical examination parameters, skin examination, and
examination for signs of liver disease.
(v) Laboratory tests including:
(A) Liver function tests; and
(B) Urinalysis.
(vi) Additional tests as necessary in the opinion of the
physician.
(b) No initial medical examination is required if
adequate records show that the employee has been examined in
accordance with the requirements of this section within the
previous six months prior to the effective date of this
standard or prior to the date of initial assignment.
(3) Periodic examinations.
(a) The employer shall provide each employee covered by
this section with a medical examination at least annually
following the initial examination. These periodic
examinations shall include at least the following elements:
(i) A brief history regarding any new exposure to
potential liver toxins, changes in drug, tobacco, and alcohol
intake, and the appearance of physical signs relating to the
liver and the skin;
(ii) The appropriate tests and examinations including
liver function tests and skin examinations; and
(iii) Appropriate additional tests or examinations as
deemed necessary by the physician.
(b) If in the physician's opinion the results of liver
function tests indicate an abnormality, the employee shall be
removed from further MDA exposure in accordance with WAC 296-155-17329. Repeat liver function tests shall be conducted
on advice of the physician.
(4) Emergency examinations. If the employer determines
that the employee has been exposed to a potentially hazardous
amount of MDA in an emergency situation under WAC 296-155-17309, the employer shall provide medical examinations
in accordance with subsection (3)(a) and (b). If the results
of liver function testing indicate an abnormality, the
employee shall be removed in accordance with WAC 296-155-17329. Repeat liver function tests shall be conducted
on the advice of the physician. If the results of the tests
are normal, tests must be repeated two to three weeks from the
initial testing. If the results of the second set of tests
are normal and on the advice of the physician, no additional
testing is required.
(5) Additional examinations. Where the employee develops
signs and symptoms associated with exposure to MDA, the
employer shall provide the employee with an additional medical
examination including liver function tests. Repeat liver
function tests shall be conducted on the advice of the
physician. If the results of the tests are normal, tests must
be repeated two to three weeks from the initial testing. If
the results of the second set of tests are normal and on the
advice of the physician, no additional testing is required.
(6) Multiple physician review mechanism.
(a) If the employer selects the initial physician who
conducts any medical examination or consultation provided to
an employee under this section, and the employee has signs or
symptoms of occupational exposure to MDA (which could include
an abnormal liver function test), and the employee disagrees
with the opinion of the examining physician, and this opinion
could affect the employee's job status, the employee may
designate an appropriate and mutually acceptable second
physician:
(i) To review any findings, determinations, or
recommendations of the initial physician; and
(ii) To conduct such examinations, consultations, and
laboratory tests as the second physician deems necessary to
facilitate this review.
(b) The employer shall promptly notify an employee of the
right to seek a second medical opinion after each occasion
that an initial physician conducts a medical examination or
consultation pursuant to this section. The employer may
condition its participation in, and payment for, the multiple
physician review mechanism upon the employee doing the
following within fifteen days after receipt of the foregoing
notification, or receipt of the initial physician's written
opinion, whichever is later:
(i) The employee informing the employer that he or she
intends to seek a second medical opinion; and
(ii) The employee initiating steps to make an appointment
with a second physician.
(c) If the findings, determinations, or recommendations
of the second physician differ from those of the initial
physician, then the employer and the employee shall assure
that efforts are made for the two physicians to resolve any
disagreement.
(d) If the two physicians have been unable to quickly
resolve their disagreement, then the employer and the employee
through their respective physicians shall designate a third
physician:
(i) To review any findings, determinations, or
recommendations of the prior physicians; and
(ii) To conduct such examinations, consultations,
laboratory tests, and discussions with the prior physicians as
the third physician deems necessary to resolve the
disagreement of the prior physicians.
(e) The employer shall act consistent with the findings,
determinations, and recommendations of the second physician,
unless the employer and the employee reach a mutually
acceptable agreement.
(f) Information provided to the examining physician.
(i) The employer shall provide the following information
to the examining physician:
(A) A copy of this regulation and its appendices;
(B) A description of the affected employee's duties as
they relate to the employee's potential exposure to MDA;
(C) The employee's current actual or representative MDA
exposure level;
(D) A description of any personal protective equipment
used or to be used; and
(E) Information from previous employment related medical
examinations of the affected employee.
(ii) The employer shall provide the foregoing information
to a second physician under this section upon request either
by the second physician, or by the employee.
(g) Physician's written opinion.
(i) For each examination under this section, the employer
shall obtain, and provide the employee with a copy of, the
examining physician's written opinion within fifteen days of
its receipt. The written opinion shall include the following:
(A) The occupationally pertinent results of the medical
examination and tests;
(B) The physician's opinion concerning whether the
employee has any detected medical conditions which would place
the employee at increased risk of material impairment of
health from exposure to MDA;
(C) The physician's recommended limitations upon the
employee's exposure to MDA or upon the employee's use of
protective clothing or equipment and respirators; and
(D) A statement that the employee has been informed by
the physician of the results of the medical examination and
any medical conditions resulting from MDA exposure which
require further explanation or treatment.
(ii) The written opinion obtained by the employer shall
not reveal specific findings or diagnoses unrelated to
occupational exposures.
[Statutory Authority: Chapter 49.17 RCW. 93-04-111 (Order
92-15), § 296-155-17327, filed 2/3/93, effective 3/15/93.]